These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


542 related items for PubMed ID: 29408358

  • 21. Sero-prevalence of hepatitis B virus markers and associated factors among children in Hawassa City, southern Ethiopia.
    Argaw B, Mihret A, Aseffa A, Tarekegne A, Hussen S, Wachamo D, Shimelis T, Howe R.
    BMC Infect Dis; 2020 Jul 22; 20(1):528. PubMed ID: 32698884
    [Abstract] [Full Text] [Related]

  • 22. [Negative HBsAg and HBsAb in Women of Child-bearing Age in Mianyang].
    Wen XH, Xiao C, Wang M, Wang L, Wang J, Ren T, Wang LP, Cheng SW, Zhang X, Zhang WH, Yuan P.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Jan 22; 48(1):107-110. PubMed ID: 28612569
    [Abstract] [Full Text] [Related]

  • 23. Reactivation of hepatitis B virus infection following rituximab treatment in HBsAg-negative, HBcAb-positive rheumatoid arthritis patients: A long-term, real-world observation.
    Chen YM, Chen HH, Huang WN, Chen YH, Hsieh TY, Yang SS, Lan JL, Chen DY.
    Int J Rheum Dis; 2019 Jun 22; 22(6):1145-1151. PubMed ID: 31117160
    [Abstract] [Full Text] [Related]

  • 24. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
    Huynh C, Minuk GY, Uhanova J, Baikie M, Wong T, Osiowy C.
    Vaccine; 2017 Aug 16; 35(35 Pt B):4515-4522. PubMed ID: 28736196
    [Abstract] [Full Text] [Related]

  • 25. Seroepidemiology of hepatitis B virus infection among Chinese schizophrenia patients.
    Zhu H, Liu X, Xue Y, Shen C, Li Y, Wang A, Ding Y, Zheng Z, Dong C.
    J Infect Dev Ctries; 2015 May 18; 9(5):512-8. PubMed ID: 25989171
    [Abstract] [Full Text] [Related]

  • 26. Hepatitis B virus in the Lao People's Democratic Republic: a cross sectional serosurvey in different cohorts.
    Black AP, Nouanthong P, Nanthavong N, Souvannaso C, Vilivong K, Jutavijittum P, Samountry B, Lütteke N, Hübschen JM, Goossens S, Quet F, Buisson Y, Muller CP.
    BMC Infect Dis; 2014 Aug 23; 14():457. PubMed ID: 25149478
    [Abstract] [Full Text] [Related]

  • 27. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages.
    Whittle HC, Maine N, Pilkington J, Mendy M, Fortuin M, Bunn J, Allison L, Howard C, Hall A.
    Lancet; 1995 Apr 29; 345(8957):1089-92. PubMed ID: 7715343
    [Abstract] [Full Text] [Related]

  • 28. [A seroepidemiologic analysis of hepatitis B in Sichuan province].
    Du F, Liu QL, Fu QP, Sun L, Ao R, Guan XJ, Liu Y, Wang J, He H, Tong WB, Qin ZY, Fan WJ, Li J, He JL, Fang G.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb 29; 30(2):139-43. PubMed ID: 19565873
    [Abstract] [Full Text] [Related]

  • 29. [Comparative analyze on hepatitis B seroepidemiological surveys among population aged 1-29 years in different epidemic regions of China in 1992 and 2014].
    Wang FZ, Zhang GM, Shen LP, Zheng H, Wang F, Miao N, Yuan QL, Sun XJ, Bi SL, Liang XF, Wang HQ.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun 06; 51(6):462-468. PubMed ID: 28592086
    [Abstract] [Full Text] [Related]

  • 30. Effectiveness of hepatitis-B vaccination in Ivory Coast: the case of the Grand Bassam health district.
    Magoni M, Ekra KD, Aka LN, Sita KS, Kanga K.
    Ann Trop Med Parasitol; 2009 Sep 06; 103(6):519-27. PubMed ID: 19695157
    [Abstract] [Full Text] [Related]

  • 31. [Sero-epidemiological analysis on hepatitis B among children aged 1-14 years old born to HBsAg positive mother in China, 2014].
    Wang FZ, Zheng H, Zhang GM, Miao N, Sun XJ, Cui FQ.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Apr 10; 38(4):457-461. PubMed ID: 28468062
    [Abstract] [Full Text] [Related]

  • 32. Seroepidemiology of hepatitis B virus infection in 2 million men aged 21-49 years in rural China: a population-based, cross-sectional study.
    Liu J, Zhang S, Wang Q, Shen H, Zhang M, Zhang Y, Yan D, Liu M.
    Lancet Infect Dis; 2016 Jan 10; 16(1):80-86. PubMed ID: 26268687
    [Abstract] [Full Text] [Related]

  • 33. Hepatitis-B virus infection in India: Findings from a nationally representative serosurvey, 2017-18.
    Murhekar MV, Santhosh Kumar M, Kamaraj P, Khan SA, Allam RR, Barde P, Dwibedi B, Kanungo S, Mohan U, Mohanty SS, Roy S, Sagar V, Savargaonkar D, Tandale BV, Topno RK, Girish Kumar CP, Sabarinathan R, Bitragunta S, Grover GS, Lakshmi PVM, Mishra CM, Sadhukhan P, Sahoo PK, Singh SK, Yadav CP, Kumar R, Dutta S, Toteja GS, Gupta N, Mehendale SM, ICMR – Serosurvey group.
    Int J Infect Dis; 2020 Nov 10; 100():455-460. PubMed ID: 32896662
    [Abstract] [Full Text] [Related]

  • 34. Hepatitis B surface antigen seroprevalence among pre- and post-vaccine cohorts in Cambodia, 2017.
    Ork V, Woodring J, Shafiqul Hossain M, Wasley A, Nagashima S, Yamamoto C, Chuon C, Sugiyama A, Ohisa M, Akita T, Ko K, Mao B, Tanaka J.
    Vaccine; 2019 Aug 14; 37(35):5059-5066. PubMed ID: 31285088
    [Abstract] [Full Text] [Related]

  • 35. Epidemiology of hepatitis B virus infection: results from a community-based study of 0.15 million residents in South China.
    Zeng F, Guo P, Huang Y, Xin W, Du Z, Zhu S, Deng Y, Zhang D, Hao Y.
    Sci Rep; 2016 Nov 07; 6():36186. PubMed ID: 27819332
    [Abstract] [Full Text] [Related]

  • 36. A serological and molecular survey of hepatitis B in children 15 years after inception of the national hepatitis B vaccination program in eastern China.
    Dong Y, Liu SL, Zhai XJ, Zhu FC, Pan H, Yu JX, Chen YZ, Xie YR, Zhang XY, Zhang HM, Li LJ, Wang H, Ruan B.
    J Med Virol; 2009 Sep 07; 81(9):1517-24. PubMed ID: 19626618
    [Abstract] [Full Text] [Related]

  • 37. Comparison between two population-based hepatitis B serosurveys with an 8-year interval in Shandong Province, China.
    Liu J, Lv J, Yan B, Feng Y, Song L, Xu A, Zhang L, Yan Y.
    Int J Infect Dis; 2017 Aug 07; 61():13-19. PubMed ID: 28577994
    [Abstract] [Full Text] [Related]

  • 38. [Seroepidemiological analysis of hepatitis B virus infection among adolescents aged 0-14 years in Henan Province and preliminary evaluation of the effectiveness of childhood hepatitis B vaccine immunization program].
    Guo YH, Chen YP, Dou QH, Liu Q, Yang JH, Seng MH, Lyu YY, Wang CS, Lu MX, Xu J, Zhang YY, Zhao DY.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2024 Feb 06; 58(2):202-207. PubMed ID: 38387951
    [Abstract] [Full Text] [Related]

  • 39. Changes in hepatitis B virus surface antibody titer and risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients undergoing biologic therapy for rheumatic diseases: a prospective cohort study.
    Tien YC, Yen HH, Li CF, Liu MP, Hsue YT, Hung MH, Chiu YM.
    Arthritis Res Ther; 2018 Nov 01; 20(1):246. PubMed ID: 30382902
    [Abstract] [Full Text] [Related]

  • 40. Analysis of epidemiological serosurvey of hepatitis B virus among people under 29 years of age in Jiangsu Province, China.
    Sun X, Zhu Y, Tang F, Deng X, Wang Z, Liu Y.
    Hum Vaccin Immunother; 2021 Oct 03; 17(10):3729-3734. PubMed ID: 34096830
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 28.